http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006210620-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c038dd7da0e9a46b6bc7a2143a6fa083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f07b4d301363c3f8d7bb89db60c7b233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4107e3a5e549bb7bd4005b12f25a3d35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ceade3381e2c3978de0631ce23754c2b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2004-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5af3d5cb975b91918b28a2d8818aef1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5759b598a2baf205484b2bd003cf4ced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d48d0419e32c98918ab161fdb38b345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34cd62352e37953212f2d554afaa471f
publicationDate 2006-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2006210620-A1
titleOfInvention Co-precipitated amorphous losartan and dosage forms comprising the same
abstract The technical field of the invention relates to spray dried, co-precipitate amorphous losartan dosage forms that are stable over time and processes for their preparation. The processes stabilize the amorphous losartan. The process includes preparing an aqueous solution of losartan and one or more hydrophilic polymers; and spray drying the aqueous solution of losartan and one or more hydrophilic polymers to form a mixture. The amorphous losartan and one or more hydrophilic polymers are co-precipitated from the aqueous solution.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006160871-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017209372-A1
priorityDate 2003-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4127647-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5138069-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5608075-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002142050-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453831981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9847164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136080371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128961263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454025817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11751549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135883348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127447154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45266664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66586697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22178470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24846132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503925

Total number of triples: 84.